Clerio Vision, Inc.

Perfecting the Sense of Sight.

Clerio Vision is developing a revolutionary product platform for the global ophthalmic market, based on technology licensed from the University of Rochester. The company is in the process of developing and commercializing a portfolio of next generation products in contact lenses, refractive as well as cataract surgery. The company has raised approximately $18 million in financing from Stonehenge Growth Equity, Armory Square Ventures, Cranberry Capital, and prominent angel investors as well as the National Science Foundation. The team is composed of serial entrepreneurs with multiple exits as well as ophthalmic industry veterans who pioneered a number of new ophthalmic technology categories including LASIK. The contact lens and non-invasive refractive surgery products are currently in clinical development.

Company’s Keywords:

refractive, laser, opthalmic, medical device, contact lenses, intraocular lenses